Pulished Date October, 2018
ID: 2702
Share on
Share on

Europe Non-Invasive Prenatal Testing Market By Instruments (Ultrasound, NGS, PCR, Microarray), Method (FCMB, Cf-DNA), By Application (Trisomy, Microdeletion, Genetics, Rh Factor), By End User (Hospital, Diagnostic Labs) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: October, 2018
ID: 2702
Pages: 142

The Europe Non-Invasive Prenatal Testing Market was worth USD 0.52 Billion in 2018 and is projected to be growing at a CAGR of 15.3%, to touch USD 1.06 Billion by 2023. Non-Invasive Prenatal Testing consists of screening tests which non-invasively determine the presence of  genetic birth defects in a fetus. This generally done by a taking a sample of the mother’s blood and analysing the cell-free DNA present in the blood.

Cell-free DNA is the DNA of the fetus which circulates in the mother’s blood during pregnancy. NIPT helps in the identification of the most common genetic disorders such as the Patau Syndrome, Edward Syndrome and the Down Syndrome. Gender determination is also possible using NIPT.

The growth of the Europe Non-Invasive Prenatal Testing Market is mainly driven by factors such as the customer preference for non-invasive screening techniques over invasive methods, growing frequency of genetic abnormalities, the rapid advances in technology and feasible reimbursement rates for NIPT. False positives which lead to lower trust on Non-Invasive Screening techniques are the major constraints of market growth.

The Europe Non-Invasive Prenatal Testing Market is segment on the basis of Instruments, Method of Screening, Application, End User and geography. Based on Instruments, the market is divided into Ultrasound, NGS, PCR and Microarray. Based on Method, the Non-Invasive Prenatal Testing Market is segmented into FCMB and cf-DNA. Further, by Application, the market is branched into Trisomy, Microdeletion, Genetics, and Rh factor. Based on the End User, it is categorized into Hospital and Diagnostic Labs.

The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy.  Europe holds the second position in terms of market share globally. There is still potential for market growth due to the presence of untapped markets and advancements in technology which might end up making the NIPT methods more trustworthy.

The important players in the Europe Non-Invasive Prenatal Testing market are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  2. Europe Ultrasound Market By Region, From 2018-2023 ( USD Billion )
  3. Europe NGS Market By Region, From 2018-2023 ( USD Billion )
  4. Europe PCR Market By Region, From 2018-2023 ( USD Billion )
  5. Europe Microarray Market By Region, From 2018-2023 ( USD Billion )
  6. Europe Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  7. Europe FCMB Market By Region, From 2018-2023 ( USD Billion )
  8. Europe cf-DNA Market By Region, From 2018-2023 ( USD Billion )
  9. Europe Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  10. Europe Trisomy Market By Region, From 2018-2023 ( USD Billion )
  11. Europe Microdeletion Market By Region, From 2018-2023 ( USD Billion )
  12. Europe Genetics Market By Region, From 2018-2023 ( USD Billion )
  13. Europe Rh Factor Market By Region, From 2018-2023 ( USD Billion )
  14. Europe Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  15. Europe Hospital Market By Region, From 2018-2023 ( USD Billion )
  16. Europe Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
  17. U.K. Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  18. U.K. Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  19. U.K. Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  20. U.K. Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  21. Germany Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  22. Germany Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  23. Germany Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  24. Germany Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  25. France Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  26. France Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  27. France Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  28. France Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  29. Italy Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  30. Italy Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  31. Italy Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  32. Italy Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  33. Spain Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  34. Spain Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  35. Spain Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  36. Spain Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients

Research Areas